Glial Fibrillary Acidic Protein: A Biomarker and Drug Target for Alzheimer’s Disease
Glial fibrillary acidic protein (GFAP) is an intermediate filament structural protein involved in cytoskeleton assembly and integrity, expressed in high abundance in activated glial cells. GFAP is neuroprotective, as knockout mice are hypersensitive to traumatic brain injury. GFAP in cerebrospinal f...
| Main Authors: | Akshatha Ganne, Meenakshisundaram Balasubramaniam, W. Sue T. Griffin, Robert J. Shmookler Reis, Srinivas Ayyadevara |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2022-06-01
|
| Series: | Pharmaceutics |
| Subjects: | |
| Online Access: | https://www.mdpi.com/1999-4923/14/7/1354 |
Similar Items
-
A Novel Microtubule-Binding Drug Attenuates and Reverses Protein Aggregation in Animal Models of Alzheimer’s Disease
by: Samuel Kakraba, et al.
Published: (2019-12-01) -
A case of glial fibrillary acidotic protein (GFAP) meningoencephalitis with rheumatoid arthritis
by: Mehri Salari, et al.
Published: (2023-03-01) -
Parainfectious Anti-Glial Fibrillary Acidic Protein-Associated Meningoencephalitis
by: Jae Young Joo, et al.
Published: (2022-01-01) -
Case report: Headache as the sole neurological symptom in autoimmune glial fibrillary acidic protein (GFAP) astrocytopathy
by: Eslam Shosha, et al.
Published: (2024-04-01) -
Autoimmune glial fibrillary acidic protein astrocytopathy associated with breast cancer: a case report
by: Tomonori Yaguchi, et al.
Published: (2023-04-01)